海洛因和芬太尼的低氧效应及其基本生理机制
1Behavioral Neuroscience Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, DHHS, Baltimore, Maryland, United States.
概括
像海洛因和芬太尼这样的阿片类药物危险地降低了大脑的氧气水平,导致呼吸抑制. 本综述探讨了这些阿片类药物如何影响大脑的氧气,以及纳洛如何可以逆转这些影响.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 呼吸系统生理学 呼吸系统生理学
背景情况:
- 片类药物,特别是海洛因和芬太尼,导致危险的呼吸抑制,减少大脑的氧气供应.
- 虽然胸膜扫描评估呼吸,但关键问题是大脑氧气水平的全球下降.
- 了解阿片类药物诱导的大脑缺氧对于管理过量和长期并发症至关重要.
研究的目的:
- 审查和讨论海洛因和芬太尼引起的大脑氧气水平的波动.
- 为了比较这些阿片类药物对大脑氧化的影响,包括延迟,效力和致命性.
- 探索纳洛在逆转阿片类药物诱导的大脑氧气变化的有效性.
主要方法:
- 在清醒,自由移动的老鼠中利用氧气传感器和高速电压计.
- 检查了大脑对自然生理刺激和阿片类药物管理的氧气反应.
- 在不同时间点对纳洛在预治疗和治疗模式中的影响进行了研究.
主要成果:
- 提出了比较海洛因和芬太尼对大脑氧气的影响的数据,包括剂量依赖性和致命性.
- 详细介绍了阿片类药物诱导的大脑氧气水平变化的潜在机制.
- 展示了纳洛在逆转阿片类药物诱导的大脑缺氧方面的有效性.
结论:
- 阿片类药物诱导的呼吸抑制显著影响大脑的氧气水平,海洛因和芬太尼表现出明显的影响.
- 纳洛在减轻阿片类药物诱导的大脑缺氧方面表现出潜力.
- 在老鼠模型中的发现为阿片类毒性和滥用阿片类药物的临床管理策略提供了洞察力.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
237
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
237
Analgesia and Pain Management
540
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
540
Opioid Analgesics: Morphine and Other Natural Cogeners
188
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
188
Opioid Receptors: Overview
555
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
555
Drug Abuse and Addiction: Pharmacological Phenomena
447
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
447
Parenteral Anesthetics: Overview
106
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
106


